Philippe C. Bishop - 09 Jan 2023 Form 4 Insider Report for Atreca, Inc.

Role
Chief Medical Officer
Signature
/s/ Courtney Phillips, attorney-in-fact
Issuer symbol
N/A
Transactions as of
09 Jan 2023
Net transactions value
$0
Form type
4
Filing time
11 Jan 2023, 17:44:13 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCEL Employee stock option (right to buy) Award $0 +350,000 $0.000000 350,000 09 Jan 2023 Class A Common Stock 350,000 $1.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares of Class A common stock underlying the Option shall vest on January 9, 2024 and the remainder of the shares of Class A common stock underlying the Option shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.